PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study

INTRODUCTION: Peroxisome proliferator-activated receptor-α (PPAR-α) agonists can regulate metabolism and protect the cardiovascular system. This study investigated the effects of PPAR-α agonist fenofibrate on insulin resistance in patients with impaired glucose tolerance (IGT). METHODS: This researc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Ther
Main Authors: Feng, Xiaomeng, Gao, Xia, Jia, Yumei, Xu, Yuan
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2017
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5380508/
https://ncbi.nlm.nih.gov/pubmed/28361462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0257-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki